Bridging the gap: mechanisms and novel translational strategies to prevent cisplatin-induced ototoxicity.

Cisplatin is a widely used chemotherapeutic agent, but its clinical utility is limited by dose-dependent ototoxicity, causing irreversible sensorineural hearing loss and significantly impairing quality of life, especially in pediatric patients. This…

Preview only. Read the full abstract at the source